Skip to main content

Table 3 Treatment, response and remission rates

From: Variability in phenotype and response to treatment in chronic nonbacterial osteomyelitis; the Irish experience of a national cohort

Medication Number of patients who used (%) No response (%) Partial response (%) Remission (%)
NSAID 44 (100) 27/44 (61.4) 11/44 (25) 6/44 (13.6)
Methotrexatea 24 (54.5) 11/24 (45.8) 6/24 (25) 7/24 (29.1)
Pamidronate 6 (13.6) 3/6 (50) 1/6b (16.7) 0
Adalimumab 15 (34) 5/15c (33.3) 6/15 (40) 4/15 (16.7)
Infliximab 7 (15.9) 2/7 (28.6) 3/7 (42.8) 2/7 (28.6)
Etanercept 4 (9.1) 2/4 (50) 1/4 (25) 1/4 (25)
  1. a. Monotherapy; does not include those who received methotrexate as an adjunct to TNF blocker
  2. b. 2 patients have received < 3 months treatment
  3. c. 1 discontinued early due to adverse reaction
\